Morality and Legality in the Use of Antiandrogenic Pharmacotherapy with Sexual Offenders

International Perspectives on the Assessment and Treatment of Sexual Offenders: Theory, Practice, and Research

Volumn , Issue , 2011, Pages 627-651

  Harrison, Karen ^a   Rainey, Bernadette ^b  

^a UNIVERSITY OF HULL   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

"aggravated form"; "direct and continuous contact with the vital forces"; Human rights law; In vitro fertilization (IVF); Legal issues; Luteinizing hormone releasing hormone (LHRH); Medroxyprogesterone acetate (MPA); Selective serotonin re uptake inhibitors (SSRIs); The ethical moral issues

Indexed keywords

EID: 83155160896     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781119990420.ch33     Document Type: Chapter

References (51)

1. Abel, G. C., Becker, J. V., Mittelman, M., Cunningham-Rathner, J., Rouleau, J. L., & Murphy, W. D. (1987). Self-reported sex crimes of nonincarcerated paraphiliacs. Journal of Interpersonal Violence, 2, 3-25.
2. Adi, Y., Ashcroft, D., Browne, K., Beech, A., Fry-Smith, A., & Hyde, C. (2002). Clinical effectiveness and cost-consequence of selective serotonin reuptake inhibitors in the treatment of sex offenders. London: Home Office.
3. Baker, W. L. (1984). Castration of the male sex offender: a legally impermissible alternative. Loyola Law Review, 30, 377-399.
4. Bartlett, P. (2007). A matter of necessity? Enforced treatment under the Mental Health Act. Medical Law Review, 15, 86-94.
5. Beech, A. R., & Mitchell, I. J. (2005). A neurobiological perspective on attachment problems in sexual offenders and the role of selective serotonin reuptake inhibitors in the treatment of such problems. Clinical Psychology Review, 25, 153-182.
6. Berlin, F. S. (1989). The paraphilias and Depo-Provera: Some medical, ethical and legal considerations. Bulletin of the American Academy of Psychiatry and Law, 17, 233-239.
7. Berner, W., & Briken, P. (2008, August). Practical aspects in the biomedical treatment of sexual offenders. Paper presented at the 10th IATSO conference, Cape Town, South Africa.
8. Bottoms, A. E. (1977). Reflections of the renaissance of dangerousness. Howard Journal, 16(2), 70-76.
9. Bowden, P. (1991). Treatment: Use, abuse and consent. Criminal Behaviour and Mental Health, 1, 130-141.
10. Bradford, J. W. (1983). The hormonal treatment of sexual offenders. Bulletin of the American Academy of Psychiatry and the Law, 11, 159-169.
11. Bradford, J. M. W., & Pawlak, A. (1993). Double-blind placebo crossover study of cyproterone acetate in the treatment of the paraphilias. Archives of Sexual Behavior, 22(5), 383-402.
12. Briere, J., & Elliott, D.M. (2003). Prevalence and psychological sequelae of self-reported childhood physical and sexual abuse in a general population sample of men and women. Child Abuse and Neglect, 27, 1205-1222.
13. Briken, P., Hill, A., & Berner, W. (2003). Pharmacotherapy of paraphilias with longacting agonists of luteinizing hormone-releasing hormone: A systematic review. Journal of Clinical Psychiatry, 64(8), 890-897.
14. Briken, P., Nika, E., & Berner, W. (2001). Treatment of paraphilia with luteinising hormone-releasing agonists. Journal of Sex & Marital Therapy, 27, 45-55.
15. Brody, A. L., & Green, R. (1994). Washington State's unscientific approach to the problem of repeat sex offenders. Bull. Am. Acad. Psychiatry L., 20, 343-356.
16. Carpenter, A. (1998). Belgium, Germany, England, Denmark and the United States: The implementation of registration and castration laws as protection against habitual sex offenders. Dickinson Journal of International Law, 16(2), 435-457.
17. Clarke, D. J. (2003). Psychiatric and behavioural problems and pharmacological treatments. In H. Morgan (Ed.), Adults with autism. A guide to theory and practice (pp. 197-230). Cambridge, UK: Cambridge University Press.
18. Connelly, C., & Williamson, S. (2000). Areview of the research literature on serious violent and sexual offenders. Edinburgh: The Scottish Executive Central Research Unit.
19. Craissati, J. (2004). Managing high risk sex offenders in the community. A psychological approach. New York: Routledge.
20. Donnelly, J. (2003). Universal human rights in theory and practice ( 2nd edn.). Ithaca, NY: Cornell University Press.
21. Feldman, D. (1999). Human dignity as a legal value: Part 1. Public Law, 682-702.
22. Fenwick, H. (2002). Civil Liberties and Human Rights ( 3rd edn.) London: Cavendish Publishing.
23. Fitzgerald, E. (1990). Chemical castration: MPA treatment of the sexual offender. American Journal of Criminal Law, 18(1), 1-60.
24. Grasswick, L. J., & Bradford, J. B. (2002). Osteoporosis associated with the treatment of paraphilias: A clinical review of seven case reports. Journal of Forensic Sciences, 48(4), 849-855.
25. Greenberg, D. M., Bradford, J. M., Curry, S., & O'Rourke, A. (1996). A comparison of treatment of paraphilias with three serotonin reuptake inhibitors: A retrospective study. Bulletin of the American Academy of Psychiatry and the Law, 24(4), 525-532.
26. Grossman, L. S., Martis, B., & Fichtner, C. G. (1999). Are sex offenders treatable? A research review. Psychiatric Services, 50(30), 349-361.
27. Grubin, D. (2007). Second expert paper: Sex offender research, NHS National Programme on Forensic Mental Health Research and Development. Liverpool: Forensic Mental Health.
28. Gys, L., & Gooren, L. (1996). Hormonal and psychopharmacological interventions in the treatment of paraphilias: An update. The Journal of Sex Research, 33(4), 273-290.
29. Harrison, K. (2007). The high-risk sex offender strategy in England and Wales: Is chemical castration an option?. The Howard Journal, 46(1), 16-31.
30. Harrison, K. (2008). Legal and ethical issues when using anti-androgenic pharmacotherapy with sex offenders. Sexual Offender Treatment, 3(2), retrieved from http://www.sexual-offender-treatment.org/2-2008_01.html.
31. Harrison, K. (2010). The use of pharmacotherapy with high-risk sex offenders. In K. Harrison (Ed.), Managing High Risk Sex Offenders in the Community Risk management, treatment and social responsibility. Cullompton, UK: Willan Publishing.
32. Harrison, K., & Rainey, B. (2009). Suppressing human rights? A rights-based approach to the use of pharmacotherapy with sex offenders. Legal Studies, 29(1), 47-74.
33. Howitt, D. (1995). Paedophiles and sexual offences against children. Chichester, UK: John Wiley and Sons.
34. Icenogle, D. L. (1994). Sentencing male sex offenders to the use of biological treatments. A constitutional analysis. The Journal of Legal Medicine, 15, 279-304.
35. Kafka, M. P. (2006, September). Pharmacological treatments for sexual offenders: How can we reduce sexual motivation and impulsivity associated with sexual offending. Paper presented at the 9th Annual IATSO conference, Hamburg, Germany.
36. Krueger, R. B., & Kaplan, M. S. (2001). Depot-Leuprolide Acetate for treatment of paraphilias: A report of twelve cases. Archives of Sexual Behavior, 30(4), 409-422.
37. Maguire, M., & Kemshall, K. (2003). Sex offenders, risk penalty and the problem of disclosure to the community. In A. Matravers (Ed.) Sex offenders in the community. Managing and reducing the risks (pp. 102-124). Cullompton, UK: Willan Publishing.
38. Maletzky, B. M., & Field, G. (2003). The biological treatment of dangerous sexual offenders: a review and preliminary report of the Oregon pilot Depo-Provera program. Aggression and Violent Behavior, 8, 391-412.
39. Meyer, W. J., & Cole, C. M. (1997). Physical and chemical castration is sex offenders: A review. Journal of Offender Rehabilitation, 25(3/4) 1-18.
40. Miller, R. (2003). Chemical castration of sex offenders: treatment or punishment. In B. J. Winick& J. Q. La Fond (Eds.), Protecting society from sexually dangerous offenders. Law, justice and therapy (pp. 249-263). Washington DC: American Psychological Association.
41. Money, J. M. (1979). Ideas and ethics of psychosexual determinism. British Journal of Sexual Medicine, May, 27-32.
42. McCormack, N. (1981). Law, morality and positivism. Legal Studies, 1(2), 131-145.
43. NOMS (2007). Medical treatment for sex offenders. Probation Circular 35/2000. London: NOMS.
44. Norman-Eady, S. (2006). Castration of Sex Offenders. Retrieved from http://www.cga.ct.gov/2006/rpt/2006-R-0183.htm
45. Ovey, R., & White, C. (2006). The European convention on human rights ( 4th ed.). Oxford, UK: Oxford University Press.
46. Rainey, B., & Harrison, K. (2008). Pharmacotherapy and human rights in sexual offenders: Best of friendsorunlikely bed fellows? Sexual Offender Treatment, 3(2), retrieved from http://www.sexual-offender-treatment.org/2-2008_02.html
47. Raymond, N. C., Grant, J. E., Kim, S.W., & Coleman, E. (2002). Treatment of compulsive sexual behaviour with naltrexone and serotonin reuptake inhibitors: two case studies. International Clinical Psychopharmacology, 17(4), 201-205.
48. Rosler, A., & Witztum, E. (2000). Pharmacotherapy of the paraphilias in the next millennium. Behavioral Sciences and the Law, 18, 43-56.
49. Savell, K. (2004). Sex and the sacred: Sterilization and bodily integrity in English and Canadian Law. McGill Law Journal, 49, 1093-1142.
50. Spalding, L. (1998). Florida's 1997 chemical castration law: a return to the dark ages. Florida State University Law Review, 25 Retrieved from: http://www.law.fsu.edu/journals/lawreview/frames/252/spalfram.html
51. Stinneford, J. F. (2006). Incapacitation through maiming: Chemical castration, the Eighth Amendment, and the denial of human dignity. University of St Thomas School of Law Legal Studies research paper No. 06 - 25 retrieved from http://papers.ssrn.com/sol3/papers.cfm?abstract_id=918271